Last reviewed · How we verify

NCT06945094: FlashV

A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.

Not yet recruiting Last updated 27 April 2025
What this trial tests

trial testing caIMR in Coronary Microvascular Dysfunction (CMD) in 508 participants. Not yet recruiting.

Timeline
1 July 2025
Primary endpoint
30 December 2027
30 December 2029

Quick facts

Lead sponsorGe Junbo
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment508
Start date1 July 2025
Primary completion30 December 2027
Estimated completion30 December 2029

Drugs / interventions tested

Conditions studied

Sponsor

Ge Junbo — full company profile →

Who can join

Adults 18 to 80, any sex, with Coronary Microvascular Dysfunction (CMD) or Stable Angina Pectoris. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The coronary angiography-derived index of microcirculatory resistance (caIMR) can be used to provide a binary assessment whether patients(with stable angina, unstable angina, suspected myocardial ischemia, or coronary artery stenosis of less than 50%, and without cardiomyopathy or obstructive epicardial coronary artery disease) have microcirculatory dysfunction, using a cutoff value of 25. This study aims to evaluate the binary classification performance of caIMR in two specific groups of patients: (1) those with caIMR values between 20 and 30, and (2) those with diffuse disease. We will do this by looking at differences in their Seattle Angina Questionnaire (SAQ) scores and their health outcomes over a three-year period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of caIMR

Trials testing the same drug.

Other recruiting trials for Coronary Microvascular Dysfunction (CMD)

Currently open trials in the same condition.

Other Ge Junbo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06945094.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing